Cerebral venous sinus thrombosis (CVST) is the least common stroke type but carries significant mortality and morbidity. Although the general impact of stroke is greater in women, differences between sexes have rarely been examined systematically and many questions about etiology, presentation and outcome of stroke in women remain 1, 2 . In a prospective study on CVST, 75% of patients were women, and they were significantly younger, had headache more often at presentation and had a better prognosis than men 1 . While the use of hormonal therapy has been identified as a major risk factor for CVST in women 3-5 , other risk factors for CVST are less well defined, and the proportion of patients on hormonal therapy who develop CVST varies widely across studies. To determine sex and hormone-related differences in clinical features, risk factors, treatment and outcome in patients with CVST, we analyzed a large cohort of consecutive cases at a tertiary neurology centre.
million people. Stroke care is centralized and a large majority of CVST patients are admitted to the stroke neurology service. Charts were reviewed by two abstractors to identify time to presentation and diagnosis, presenting symptoms, risk factors for CVST, treatment received and outcome. Outcome was assessed at the time of last assessment, which was either on discharge from hospital, or at follow up appointment in clinic. We compared men to women with and without hormone-related risk factors. Hormone-related risk factors included use of systemic hormonal contraception, use of other hormonal therapy, pregnancy and the puerparium. Ethics approval was obtained from the Foothills Medical Centre institutional review board. Descriptive statistics were used to summarize characteristics of the identified cohort.
RESULTS
Hormone-related risk factors, obesity, infection and thrombophilias were the most common risk factors (Table 1) . Hormone-related risk factors were seen in most of the women younger than 40 years-of-age. Of the 44 women with hormonerelated risk factors, 30 were on oral contraceptive pills, 11 were pregnant or in the peripartum period and six were on other hormone therapies. Infection was the most common predisposing factor in men and men were significantly more likely to have a primary thrombophilia or recent head and neck trauma. Women without hormone-related risk factors were significantly more likely to have a systemic inflammatory disorder. Sixty-two percent of patients had greater than one predisposing factor while 10% had no identifiable cause. Median time from symptom onset to hospital admission in the whole cohort was four days: 7 days in men, 3.5 days in women without hormone-related risk factors and 3 days in women with hormone-related risk factors (p=0.51, Kruskal-Wallis). Diagnosis was delayed for greater than 24 hours following hospital admission in 29%: 37% of men, 18% of women without hormone-related risk factors and 29% of women with hormonerelated risk factors (p=0.37, Kruskal-Wallis).
The most common presentation among all patients was headache (82%), followed by a focal neurologic deficit (44%), nausea/vomiting (38%), altered level of consciousness (34%) and seizures (27%) (Figure) . The superior sagittal sinus was the most commonly involved venous structure in all patients (63%) with no sex difference. Anticoagulation (intravenous heparin, low molecular weight heparin or warfarin) was used in 94% of the cohort. Overall mortality was 6% (Table 2) . Complications were frequent, particularly among women without hormone-related risk factors; the most common were venous infarction, intracranial hemorrhage and subarachnoid hemorrhage. Of survivors, a persisting deficit lasting until discharge was more common in men (54% vs. 35% and 32%, p = 0.036). There was a trend for women with hormone-related risk factors to have less residual focal neurologic deficit than the other groups (5% vs. 15% and 17%, p=0.051).
DISCUSSION
Our study demonstrates important sex differences in CVST as well as differences between women with and women without hormone-related risk factors. Our results confirm that the sex predominance is most evident in younger women and is minimized in the older population 1, [6] [7] [8] . Risk factors differ between sexes, knowledge of which may improve diagnosis. A large proportion of women have hormone-related risk factors, consistent with existing literature 1, 9 . Thrombophilia and recent head and neck trauma are important predisposing risk factors in men.
Consistent with the literature, the most common presentation among all patients is headache 1, 7, 10, 11 . We found no statistical differences in the presentations between the different groups. Although our results require confirmation, they highlight the need to consider CVST in patients with a variety of neurologic signs.
Although the randomized trial evidence is far from convincing [12] [13] [14] , the consensus in the stroke field is that anticoagulation is the appropriate treatment; nearly all patients in our cohort, irrespective of sex, were treated with anticoagulation, suggesting that this treatment is now considered standard of care 10 .
Mortality in patients with CVST remains significant 1,10,15 . Coutinho et al 1 found that men had a higher mortality rate than women, the difference being exclusively caused by better outcome in women with hormone-related risk factors. The higher mortality in men is likely due to the fact that the diagnosis is delayed. We found a trend to higher mortality rate in women without hormone-related risk factors, perhaps due to older age, greater involvement of the deep venous system and higher complication rates. Sex differences in pathophysiology require further study. If confirmed elsewhere, the difference in mortality would suggest a need to be more aggressive in diagnosis and management in this population.
Our study's strengths lie in the large cohort representing ten years of experience in one centre and our focus on sex differences in CVST. However, our study has potential limitations including: incomplete case ascertainment, limited follow-up data and the inherent problems of a retrospective chart review including being restricted to the available data.
Further study is required to determine if improved recognition of sex differences in CVST may lead to more timely diagnosis and more favourable outcomes.
